Beverages containing iron compounds and ceramides

By blending glycosphingolipids, iron compounds, and collagen peptides in beverages, the dispersibility and metallic taste issues are addressed, resulting in improved beverage quality.

JP2026183081APending Publication Date: 2026-11-19TAISHO PHARMACEUTICAL CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2026206199
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-25
Filing Date
2026-09-15
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Beverages containing glucosylceramide and iron compounds face issues with poor dispersibility and unpleasant metallic taste due to the formation of precipitates, which affect product quality and consumer experience.

Method used

Incorporating specific amounts of glycosphingolipids, iron compounds, and collagen peptides into beverages to improve dispersibility and reduce the metallic taste of iron.

Benefits of technology

The solution enhances the dispersibility of glucosylceramide precipitates and reduces the unpleasant metallic taste, providing a more palatable and high-quality beverage experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026183081000001
    Figure 2026183081000001
  • Figure 2026183081000002
    Figure 2026183081000002
  • Figure 2026183081000003
    Figure 2026183081000003
Patent Text Reader

Abstract

An object of the present invention is to provide a beverage containing an iron compound in an amount of 0.006 w / w% or more in terms of iron, that reduces the unpleasant taste derived from iron (iron taste). Another object is to improve the dispersibility of precipitates derived from glycosphingolipids . [Solution to Problem] In a beverage containing an iron compound in an amount of 0.006 w / w% or more in terms of iron, the unpleasant taste derived from iron (iron taste) perceived due to the presence of iron was found to be reduced by blending glycosphingolipids. On the other hand, it was discovered that the dispersibility of precipitates derived from glycosphingolipids in the beverage is improved by blending a certain amount or more of the iron compound. That is, the present invention is a beverage comprising glycosphingolipids and an iron compound, wherein the content of the iron compound is 0.006 w / w% or more and 0.2 w / w% or less in terms of iron. Further, when a collagen peptide is further blended, the dispersibility of precipitates derived from glycosphingolipids is further improved in the beverage. ​​
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to a beverage containing an iron compound and a glycosphingolipid, which can be used in the fields of pharmaceuticals, quasi-pharmaceutical products, and foods and the like.

BACKGROUND ART

[0002] In the inner beauty market, ceramide, which is a type of glycosphingolipid, is an ingredient showing a high growth rate. Since the launch of the Foods with Function Claims system in 2015, ceramide has been increasingly adopted as a functional related ingredient, and its sales have been growing (Non-Patent Document 1). Sphingolipids are a group of lipids sharing a common skeleton of sphingoid bases, which are long-chain amino alcohols, and a wide variety of molecular species exist. Sphingolipids present in nature have a basic structure of ceramide, in which a fatty acid is amide-bonded to a sphingoid base, and exist in forms such as sphingomyelin, where phosphorylcholine is bonded to the sphingoid base moiety of ceramide, and glycosphingolipids, where a sugar is bonded thereto (Non-Patent Document 2). In the fields of foods and dietary supplements, glucosylceramide, which is a specific type of glycosphingolipid, is particularly actively utilized. .

[0003] In recent years, the use of collagen peptides has become widespread in the fields of foods and dietary supplements. Collagen is the most abundant protein in the animal body, and collagen peptides are produced by methods such as hydrolyzing collagen obtained from animals or fish to adjust the molecular weight to several hundred to several thousand, so as to improve their applicability (Non-Patent Document 3). The collagen peptide market is expanding rapidly, and collagen peptides have become an indispensable appealing ingredient especially in products targeted at women. ​​​​​​​

[0004] However, glucosylceramide is poorly soluble in water, and when applied to beverages, it has poor dispersibility. There was a problem with the formation of poorly dispersed precipitates. These poorly dispersed precipitates resulted in an unpleasant texture when taken. This can lead to residue of ingredients in the container and should be improved as much as possible to enhance the product's value. To solve this problem, a method using lecithin in combination (Patent Document 1), xanthan A method using gum and gellan gum in combination has been reported (Patent Document 2). Patent Document 1 The method described above has the challenge of requiring a reduction in the particle size of glucosylceramide. The method described in Patent Document 2 involves the formulation of xanthan gum and gellan gum to produce a unique viscosity. There are challenges such as controlling sexual activity and increased costs. Therefore, taking glucosylceramide... The method of incorporating it into the formula still has room for improvement. On the other hand, despite iron being an essential metal for living organisms, the recommended daily intake is particularly low for women. Conversely, it has been reported that this is often deficient. (Japanese Dietary Reference Intakes (2020 Edition)) In the 2018 National Health and Nutrition Survey, the recommended daily intake of iron for women was 10.5 mg, but The average iron intake for women is 7.5 mg, meaning they are deficient in iron by about 3 mg per day (unpatented). Reference 1). As an efficient method of intake through diet, beverages and supplements containing iron compounds. Although iron compounds are used, they can react with other ingredients, impairing the flavor and quality. There was a problem (Patent Documents 3 and 4). [Prior art documents] [Non-patent literature]

[0005] [Non-Patent Document 1] 2018 Inner Beauty Market Analysis Survey, p.17

Non-Patent Document 2

Non-Patent Document 3

Patent Documents

[0006]

Patent Document 1

Patent Document 2

Patent Document 3

Patent Document 4

Summary of Invention

Problem to be Solved by the Invention

[0007] An object of the present invention is to reduce the unpleasant taste derived from iron (iron taste) in a beverage containing an iron compound in an amount of 0.006 w / w% or more in terms of iron content, and to improve the dispersibility of precipitates derived from sphingoglycolipids.

Means for Solving the Problem

[0008] As a result of intensive studies to solve this problem, the present inventors have unexpectedly found that, in a beverage containing an iron compound in an amount of 0.006 w / w% or more in terms of iron content, the unpleasant taste derived from iron (iron taste) perceived due to the presence of iron can be reduced by incorporating a sphingoglycolipid. On the other hand, the present inventors have found that the dispersibility of precipitates derived from sphingoglycolipids in a beverage is improved by blending a certain amount or more of an iron compound. Further, when a certain amount of sphingoglycolipid is blended in a beverage, in addition to blending a certain amount of iron compound​​​ and further blending a collagen peptide, the dispersibility of the precipitate derived from glycosphingolipid was found to be improved. Furthermore, it was found that the dispersibility of the precipitate derived from glycosphingolipid is improved by blending a certain amount of collagen peptide in addition to blending a certain amount of iron compound. It was found that this can be achieved.

[0009] The aspects of the present invention obtained from such findings are as follows. (1) A beverage comprising a glycosphingolipid and an iron compound, wherein the content of the iron compound is 0.00 in terms of iron 6 to 0.2 w / w% (excluding beverages containing 0.01 w / w% of ammonium iron citrate in terms of iron, 2 w / w% of collagen peptide, 0.006 w / w% of glucosylceramide, 8.0 w / w% of carbohydrates, 0.02 w / w% of hyaluronic acid, erythritol, reduced starch syrup, trehalose, pectin, acesulfame potassium, sucralose, and vitamin B2). / w%, collagen peptide 2 w / w%, glucosylceramide 0.006 w / w%, carbohydrate content 8.0 w / w%, hyaluronic acid 0.02 w / w%, erythritol, reduced starch syrup, trehalose, pectin, acesulfame potassium, sucralose, and vitamin B2. A beverage containing the same (excluding the beverage described above). excluding beverages containing the same). (2) A beverage comprising a glycosphingolipid, an iron compound, and a collagen peptide, wherein the iron compound content is 0.006 to 0.2 w / w% in terms of iron, and the glycosphingolipid content is 0.00001 to 0.0052 w / w%. (3) A beverage comprising a glycosphingolipid, an iron compound, and a collagen peptide, wherein the content of the iron compound is 0.006 to 0.04 w / w% in terms of iron, and the content of the collagen peptide is 400 parts by mass or more per 1 part by mass of the glycosphingolipid. A beverage as described above. (4) The beverage according to (1) or (3), wherein the content of the glycosphingolipid is 0.00001 to 0.02 w / w%. The beverage according to (3). (5) The iron compound is selected from the group consisting of ferrous fumarate, ferric chloride, iron citrate, and ammonium iron citrate. , sodium ferrous citrate, ferrous gluconate, iron lactate, ferrous pyrophosphate, and pyrophosphoric acid At least one selected from the group consisting of ferric acid, ferrous sulfate, and heme iron, ( 1) to (4) The beverages listed above, (6) Sphingoglycolipids derived from rice, pineapple, corn, or konjac The beverages listed in (1) to (5), (7) The sphingoglycolipid is glucosylceramide, as described in any of (1) to (6). beverages, (8) Collagen peptide content is 0.02-50 w / w%, (2)-(7) The beverages listed in any of the following: (9) The iron compound content is 0.1 to 100 units in terms of iron per 1 part by mass of sphingoglycolipid. The beverage, which is a part by mass, as described in any of (1) to (8). (10) The amount of iron compounds per oral intake is 3 mg to 20 mg in iron equivalent. , a beverage listed in any of (1) to (9), (11) A beverage described in any of (1) to (10) with a pH of 2.0 to 4.5. (12) By incorporating iron compounds and collagen peptides, the sphingo in the beverage A method for improving the dispersibility of glycolipid-derived precipitates. That is the case. [Effects of the Invention]

[0010] This invention makes it possible to provide a beverage with reduced unpleasant iron-derived taste (iron taste). Furthermore, it is possible to provide a beverage with improved dispersibility of precipitates derived from sphingoglycolipids. That's what happened. [Modes for carrying out the invention]

[0011] In this invention, "sphingoglycolipid" refers to a sphingoid base to which glucose is bonded. Combined glucosylceramide, galactosyl sphingoid base with galactose bonded to it Ceramide, ganglioside (a sphingoid base bonded to sialic acid), sphingoid salts Examples include lactosylceramide, in which lactose is bonded to the base, and more preferably glucosylceramide. Ceramides can be used. One or more of these may be used as a mixture. It may be in its natural state, extracted from the tissues of mammals such as cattle and horses, or extracted from plants. This is also acceptable. Preferably, rice, rice bran, beets, wheat, corn, soybeans, konjac. It is extracted from plants such as potatoes, pineapples, grains, legumes, potatoes, and fruits. More preferably, it is derived from rice, pineapple, corn, and konjac potato. As for the "sphingoglycolipid" in the definition, commercially available products may be used, for example, pine sera powder. Maruzen Pharmaceutical Co., Ltd.), Pine Cera Emulsion (Maruzen Pharmaceutical Co., Ltd.), Brightening Pine Powder ( Maruzen Pharmaceutical Co., Ltd.), Brightening Pine Emulsion (Maruzen Pharmaceutical Co., Ltd.), Oryza Ceramide ( (Registered Trademark)-PCD (Oryza Oil & Fat Chemical Co., Ltd.), Oryza Ceramide (Registered Trademark)-WSP (Oryza (Oryza Oil & Fat Chemical Co., Ltd.), Oryza Ceramide (Registered Trademark)-L (Oryza Oil & Fat Chemical Co., Ltd.), Nippon Ceramide DoRPS (Nippon Factory Co., Ltd.), Nippon Ceramide RLG (Nippon Factory Co., Ltd.), Nippon Se Lamid CP (Nippon Factory Co., Ltd.), Phytoceramide (Ichimaru Falcos Co., Ltd.), Phytoceramide Ra NW-1 (Ichimaru Falcos Co., Ltd.), Phytosera NW-10 (Ichimaru Falcos Co., Ltd.) Phytoceramide L (Ichimaru Falcos Co., Ltd.), Konjac Ceramide (Daicel Corporation) ), Bead Ceramide EX-1 (Meiji Food Materia Co., Ltd.), Konjac Ceramide (Uni Chika Co., Ltd., Corn Ceramide ME-1 (Tsuji Oil Co., Ltd.), Corn Ceramide P10 (Tsuji Oil Co., Ltd.) Examples include oil (from Megmilk Co., Ltd.) and milk ceramide MC-5 (from Megmilk Snow Brand Co., Ltd.).

[0012] From the viewpoint of the effects of the present invention, the sphingoglycolipid content in the beverage should be 0.00001 to 0 0.02 w / w% is preferred, 0.0001 to 0.01 w / w% is more preferred, and 0.00 A concentration of 0.02-0.005 w / w% is even more preferable.

[0013] In this invention, the origin of "collagen peptide" is not particularly limited and may be synthesized. It is also possible to extract it from skin, bones, ligaments, tendons, cartilage, etc., which are by-products when processing livestock such as cattle and pigs or fish. It may be collagen peptides produced from excreted material, but porcine-derived collagen peptides Preferred. Collagen obtained by decomposing collagen protein with enzymes or chemical treatments. Collagen peptides are preferred. The average molecular weight of collagen peptides is not particularly limited, but Preferably, it is between 100 and 50,000, and more preferably between 1,000 and 25,000. The collagen peptide of this invention may be a commercially available product, for example, "Nippi Pepta" "Ido PS-1" (manufactured by Nippi Corporation), "Nippi Peptide PRA-P" (manufactured by Nippi Corporation) ), "Nippi Peptide FCP-EX" (manufactured by Nippi Corporation), "HACP-CF" (gelatin (Manufactured by Isu Co., Ltd.), "HACP-TF" (Manufactured by Zerice Co., Ltd.), "ColaPep PU" (Nitta Zerice Co., Ltd.) Latin Co., Ltd., "ColaPep JB" (Nitta Gelatin Co., Ltd.), "HDL-50SP" (Manufactured by Nitta Gelatin Co., Ltd.), "SCP-3100" (Manufactured by Nitta Gelatin Co., Ltd.), "pep Examples include the "tan P2000HD" (manufactured by Ruslo Co., Ltd.).

[0014] The collagen peptide content in the beverage of the present invention is preferably 0.02 to 50 w / w%. 0.2 to 30 w / w% is more preferred, and 0.2 to 20 w / w% is even more preferred.

[0015] Furthermore, from the viewpoint of the effects of the present invention, the collagen peptide content in the beverage is sphingo Preferably 50 to 100,000 parts by mass, and 200 to 10,000 parts by mass per 1 part by mass of glycolipid. Parts by mass are more preferable, 400 to 10000 parts by mass are even more preferable, and 700 to 10000 parts by mass are preferable. A mass portion is even more preferable. Furthermore, the collagen peptide content should be in terms of iron equivalent, i.e., 1 unit of iron. Preferably 1 to 2000 parts by mass, more preferably 10 to 1500 parts by mass, and 2 A range of 0 to 1500 parts by mass is even more preferable.

[0016] In this invention, "iron compound" refers to either a divalent iron compound or a trivalent iron compound. Also commonly, for example, ferrous fumarate, ferric chloride, iron citrate, ammonium iron citrate, Sodium ferrous citrate, ferrous gluconate, ferric lactate, ferrous pyrophosphate, pyrophosphate Examples include ferric iron, ferrous sulfate, and heme iron. In the present invention, the content of iron compounds is, in terms of iron equivalent, in a beverage, from the viewpoint of the effects of the present invention. The ratio is preferably 0.006 to 0.2 w / w%, and more preferably 0.006 to 0.04 w / w%. Furthermore, the iron compound is preferably 0.03 to 1.2 w / w%, and 0.03 to 0.6 w / w% is more preferable. The content of iron compounds is, per 1 part by mass of sphingoglycolipid, iron conversion The amount is preferably 0.1 to 100 parts by mass, and more preferably 0.5 to 50 parts by mass. Furthermore, the iron compound content in the beverage of the present invention is preferably per single oral intake. In terms of the amount of iron compound, 3 mg to 20 mg in iron equivalent is more preferable.

[0017] The beverage of the present invention can supplement more than the daily iron deficiency (3 mg or more) with a single oral intake. Cut.

[0018] Furthermore, the amount of one oral intake refers to the amount of the beverage of the present invention that is ingested orally at one time, for example, 30-200ml, typically 30ml, 50ml, 100ml, 150ml, 200ml The quantity is in milliliters. When filling by weight using density and specific gravity, for example, 15-200g. In terms of quantity, these are 15g, 30g, 50g, 100g, 150g, and 200g. The form of the beverage container when the beverage is packaged in a container is not particularly limited. The capacity of the container is not particularly limited. It is not fixed, but for example, 30ml to 200ml (typically 50ml, 100ml, 150ml) (ml, or 200ml), when filling by weight, for example 15g to 200g (typically) It can be 15g, 30g, 50g, 100g, 150g, or 200g.

[0019] In this invention, the term "beverage" is not particularly limited as long as it is a liquid that can be taken orally, and includes pharmaceuticals and medicines. This includes quasi-drugs or foods (including not only general foods but also nutritional functional foods and foods for specified health uses). This can be done. Examples of pharmaceuticals and quasi-drugs include oral liquid preparations and drinkable preparations. It can be used as a food product. Examples include soft drinks, carbonated drinks, sports / functional drinks, and non-alcoholic beverages. Examples include alcoholic beverages, dairy beverages, tea beverages, coffee beverages, fruit and vegetable beverages, and jelly drinks. It can be done. More preferably, if it is a pharmaceutical or quasi-drug, it can be an oral solution, a drink, or a food. In that case, these would be various beverages such as nutritional functional foods, foods for specified health uses, carbonated drinks, and jelly drinks.

[0020] The pH of the beverage of the present invention is not particularly limited, but is generally between 2.0 and 4 in terms of palatability. A pH of 0.5 is preferred, and 2.5 to 4.0 is more preferred. To maintain the pH within the above range, it may be necessary to... Depending on the circumstances, pH adjusters such as organic acids may be added.

[0021] Furthermore, the calorie content of the beverage of the present invention is preferably 150 kcal / 100g or less, and more preferably 150 kcal / 100g or less. More preferably 0.5-100kcal / 100g, and even more preferably 1-70kcal / It is 100g.

[0022] The beverage of the present invention can be manufactured by conventional methods, and the method is not particularly limited. No. Typically, each component is measured out, dissolved in an appropriate amount of purified water, stirred, and then the pH is adjusted. It is obtained by adding purified water to adjust the volume, and then filtering and sterilizing as necessary.

[0023] Furthermore, the beverage of the present invention also contains vitamins, minerals, amino acids, and other ingredients. The present invention includes salts of bison, crude drugs, crude drug extracts, caffeine, royal jelly, dextrin, etc. It can be added as appropriate, within a range that does not impair its effects. Furthermore, antioxidants can be added as needed. Additives such as colorants, flavorings, tasters, preservatives, sweeteners, and acidulants are not used in a manner that impairs the effects of the present invention. It can be blended appropriately within a certain range. [Examples]

[0024] The present invention will be described in more detail below with reference to examples and comparative examples.

[0025] (Evaluation of the taste of iron) The formulations listed in Tables 2-4 below were prepared according to the following method. First, citric acid and ferric ammonium citrate were prepared. Monium was dissolved in purified water to obtain a citric acid solution and an iron solution. Glucosylceramide-containing raw material. (Rice germ extract A, pineapple fruit extract, corn extract, konjac extract) Measure out the amount, add the citric acid solution and iron solution, add the sodium benzoate, and stir thoroughly. Then, purified water was added until it was almost completely dissolved, and after stirring thoroughly, hydrochloric acid or sodium hydroxide was added. The pH was adjusted using Um, and purified water was added to adjust the weight to obtain the total volume, thus obtaining the beverage. Fill each of the beverage into screw-top tubes No. 7 (manufactured by Maruemu Co., Ltd.) with 50 ml of the beverage and heat at 80°C for 25 minutes. Sterilization was performed for several minutes. Rice germ extract A is NIPPON ceramide RPS (manufactured by NIPPON CINK), pineapple fruit extract The excrete is Pine Ceramide Emulsion (manufactured by Maruzen Pharmaceutical Co., Ltd.), and the corn extract is Nippun Ceramide. CP (manufactured by Nippon Flour Mills Co., Ltd.), konjac extract is konjac ceramide (emulsified liquid type) We used a product manufactured by Daicel Corporation. Rice germ extract A is a raw material extracted from rice and processed into a powder, and contains sphingoglycolipids. The raw material used contains 6.4% of glucosylceramide, a type of pineapple fruit. The fruit extract is extracted from pineapple, processed into a liquid, and contains a type of sphingoglycolipid called glucosulfate. The raw material used contains 1.09% glucosylceramide from corn extract. The mid content is 3.3%, while the glucosylceramide content of konjac extract is 0.43%. That was the case. Regarding the beverage prepared as described above and stored at room temperature, the formulation does not contain glucosylceramide. When comparative examples 1-6) are poured into a cup and the metallic taste perceived in the mouth is evaluated using a Visual Aspect Ratio (VAS). The evaluation was performed using the VAS (Visual Analog Scale) method. The VAS method is a scale that measures taste function in basic tastes. Development of a juvenile examination method (J. Jpn. Soc. Stomattognath. Funct. 20:115-129) 2014) and "Daily Odor Questionnaire for Simple Olfactory Evaluation" (Jpn. Ninthrina 48(1):1 See ~7. 2009). That is, close both ends of a 10cm horizontal line with short vertical lines. The leftmost point represents "no metallic taste," and the rightmost point represents "very metallic taste," with the degree of metallic taste indicated vertically on the line. The data was represented by lines, and the distance from the left edge to the vertical line was measured and used as the VAS score. The evaluation was conducted by a panel of four experts. The evaluation was conducted by name, and the average value is shown. Evaluation of formulations containing glucosylceramide (Examples 2-6) This controlled the formulations containing the same amount of iron but without glucosylceramide (Comparative Examples 2-6). The iron taste was evaluated according to the criteria in Table 1.

[0026] [Table 1]

[0027] [Table 2] As shown in Table 2, Comparative Example 1 had a significantly weaker iron taste and presented no problems. In Comparative Examples 2-6... I could really taste the metallic flavor.

[0028] [Table 3] As shown in Table 3, Example 2 is Comparative Example 2, and Examples 3-1 to 3-4 are Comparative Examples 3 and 4. Compared to Comparative Example 4, Example 5, and Example 6, the iron taste was significantly weaker. .

[0029] [Table 4] As shown in Table 4, compared to Comparative Example 3, Examples 3-5 to 3-7 had a weaker iron taste, and the raw materials Changing the type of ingredient also had the effect of reducing the metallic taste.

[0030] (Evaluation of variance) The formulations listed in Tables 5-10 below were prepared according to the following method. First, citric acid and iron citrate were prepared. Ammonium was dissolved in purified water to obtain citric acid solution and iron solution. Glucosylceramide-containing Ingredients (rice germ extract or pineapple fruit extract, corn extract, konjac extract) Weigh out the substance, add citric acid solution and iron solution, add sodium benzoate, and thoroughly Stirred. If collagen peptides are included, add them after the glucosylceramide-containing ingredients. Then, purified water was added until it was almost completely dissolved, and after stirring thoroughly, hydrochloric acid or sodium hydroxide was added. The pH was adjusted using Um, and purified water was added to adjust the weight to obtain the total volume, thus obtaining the beverage. Fill each of the beverage into screw-top tubes No. 7 (manufactured by Maruemu Co., Ltd.) with 50 ml of the beverage and heat at 80°C for 25 minutes. Sterilization was performed for several minutes. Collagen peptides include Colapep JB (derived from pigs, molecular weight approximately 5000, manufactured by Nitta Gelatin Co., Ltd.) Nippi Peptide PRA-P (derived from pigs, molecular weight approximately 4000-12000, manufactured by Nippi Corporation), Nippi Pipetide FCP-EX (fish-derived, molecular weight approximately 4000, manufactured by Nippi Corporation) was used. Rice germ extract A is Nippun Ceramide RPS (manufactured by Nippun Co., Ltd.), rice germ extract. B is Nippun Ceramide DORLG (manufactured by Nippon Flour Mills Co., Ltd.), pineapple fruit extract is PineCera Powder (Maruzen Pharmaceutical Co., Ltd.) Corn extract (manufactured by Nippon Pharma Corporation), konjac The extract used was konjac ceramide (powder type) (manufactured by Daicel Corporation). Rice germ extract A is a raw material extracted from rice and processed into a powder, and is a sphingoglycolipid. The raw material used contains 6.4% glucosylceramide, which is a seed. Rice germ extract B is It is a raw material extracted from rice and processed into a liquid form, and is a type of sphingoglycolipid called glucosylglyceride. The ingredients used contain 3.8% lamidopropyl benzyl sulfate. Pineapple fruit extract is derived from pineapple. It is a raw material extracted from and processed into a powder, and is a type of sphingoglycolipid called glucosyl The ceramide content was 4.5%. (Corn extract glucosylceramide content) The total amount was 3.3%, and the glucosylceramide content of the konjac extract was 3.8%. The dispersibility of the beverages prepared as described above and stored at room temperature was evaluated according to the criteria shown in Table 11. did.

[0031] [Table 5]

[0032] As shown in Table 5, for beverages containing 0.0006 w / w% glucosylceramide, Compared to a beverage containing an iron compound at 0.002 w / w% in iron equivalent (Comparative Example 7-1), iron content In a beverage containing the compound at an iron equivalent of 0.01 w / w% (Example 7-1), the dispersibility was improved. An improvement in dispersibility was observed with the iron compound. Furthermore, the iron compound was found to be 0.002 w / w in iron equivalent. Compared to a beverage containing % (Comparative Example 7-1), the collagen peptide is further increased to 4.0 w / w In the beverage containing % of the ingredient (Comparative Example 7-2), no significant effect on dispersibility was observed. In the range of low iron concentration, no effect of improving dispersibility by collagen peptides was observed. It was. On the other hand, it contains iron compounds at 0.01 w / w% in iron equivalent, and collagen peptides at 4.0 w / w In the beverage containing % of the ingredient (Example 7-2), a significant improvement in dispersibility was observed. In addition, the glucosylceramide content of Comparative Example 7-1 was 0.3 mg per 50 g of beverage. Therefore, the content is 0.0006 w / w%, and the iron compound content is equivalent to 1 mg of iron. Therefore, it is 0.002 w / w%.

[0033] [Table 6]

[0034] As shown in Table 6, for beverages containing 0.0026 w / w% glucosylceramide, iron Compared to beverages containing the compound at an iron equivalent of 0.006-0.04 w / w% (Comparative Examples 8-10) In beverages containing 0.2-15 w / w% collagen peptides (Examples 8-10), A significant improvement in dispersibility was confirmed. The improvement in dispersibility remained the same even when the type of collagen was changed. That was the case. Furthermore, as shown in Examples 9-1 to 9-3, the dispersibility is dependent on the amount of collagen peptide used. It was confirmed that the improvement effect was enhanced.

[0035] [Table 7]

[0036] As shown in Table 7, the beverage containing collagen peptides in addition to Comparative Example 11 showed significant differences. A significant improvement in dispersion was achieved (Example 11).

[0037] Furthermore, in a beverage containing 2 w / w% collagen peptide compared to Comparative Example 12-1, Although no dispersion improvement effect was obtained (Comparative Example 12-2), further collagen peptide was added. A significant improvement in dispersibility was observed in beverages containing the compound at a w / w% concentration (Example 12). Therefore, the glucosylceramide content should be 0.0052 w / w% or less, or By adjusting the ratio of collagen peptide content to 1 part by mass of glucosylceramide It was shown that a significant improvement in diversification can be obtained.

[0038] [Table 8]

[0039] As shown in Table 8, a significant improvement in dispersibility was confirmed even at pH 4.0. Example 13).

[0040] [Table 9]

[0041] As shown in Table 9, the dispersibility-improving effect was also observed for glucosylceramide derived from rice germ extract B. This was confirmed (Example 14). In addition, pineapple fruit extract and corn extract were also found. Even when using glucosylceramide derived from konjac extract, the dispersibility improvement effect is still present. Confirmed (Examples 15, 16, 17).

[0042] [Table 10] As shown in Table 10, sodium ferrous citrate was used instead of ammonium iron citrate. In some cases, precipitation was observed even when left standing, but the dispersion improved when collagen peptide was added. Improved (Example 18).

[0043] [Table 11] [Industrial applicability]

[0044] According to the present invention, when an iron compound is blended at an iron equivalent of 0.006 w / w% or more, sphing Adjust the amount of goglycolipids, or the ratio of sphingoglycolipids to collagen peptides. This made it possible to improve the dispersibility of precipitates derived from sphingoglycolipids. Furthermore, when iron compounds are included at a concentration of 0.006 w / w% or more in terms of iron, an unpleasant taste derived from iron (iron The taste was reduced by incorporating sphingoglycolipids. Therefore, pharmaceuticals, quasi-drugs, and food products. In this field, it is expected that they will provide beverages with high commercial value.

Claims

1. It contains sphingoglycolipids and iron compounds, with an iron compound content of 0.006 to 0 in iron equivalent. • Beverages containing 2 w / w% iron (however, ammonium ferric citrate is 0.01 w / w% in iron equivalent). Collagen peptide 2 w / w%, glucosylceramide 0.006 w / w%, carbohydrate amount 8.0 w / w%, hyaluronic acid 0.02 w / w%, erythritol, reduced starch syrup, trehalose Contains sesame, pectin, acesulfame potassium, sucralose, and vitamin B2. (Excluding beverages).

2. It contains sphingoglycolipids, iron compounds, and collagen peptides, and the content of the iron compounds is iron Converted to 0.006-0.2 w / w%, the sphingoglycolipid content is 0.00001-0. A beverage with a content of 0.052 w / w%.

3. It contains sphingoglycolipids, iron compounds, and collagen peptides, and the amount of iron compounds is equivalent to the amount of iron. The collagen peptide content is 0.006 to 0.04 w / w%, and the content of sphingoglycolipids is 1. A beverage containing 400 parts by mass or more relative to the volume.

4. Claim 1 or 3, wherein the sphingoglycolipid content is 0.00001 to 0.02 w / w% The beverages listed.

5. Iron compounds include ferrous fumarate, ferric chloride, iron citrate, ammonium iron citrate, and cucumber. Sodium ferrous phosphate, ferrous gluconate, ferrous lactate, ferrous pyrophosphate, diphosphate Claim 1, at least one selected from the group consisting of iron, ferrous sulfate, and heme iron. The beverages listed in section 4.

6. If the sphingoglycolipid is derived from rice, pineapple, corn, or konjac, please The beverages listed in items 1 to 5.

7. The beverage according to any one of claims 1 to 6, wherein the sphingoglycolipid is glucosylceramide.

8. Any of claims 2 to 7, wherein the collagen peptide content is 0.02 to 50 w / w% The beverages listed.

9. The iron compound content is 0.1 to 100 parts by mass in terms of iron per 1 part by mass of sphingoglycolipid. The beverage according to any one of claims 1 to 8.

10. Claim: The amount of iron compound per single oral intake is 3 mg to 20 mg in iron equivalent. A beverage listed in any of the numbers 1 through 9.

11. A beverage according to any one of claims 1 to 10, wherein the pH is 2.0 to 4.

5.

12. By incorporating iron compounds and collagen peptides, the sphingoglycolipids in the beverage are reduced. A method for improving the dispersibility of conventional precipitates.

Citation Information

Patent Citations

  • Drink fortified with iron

    JP2000279143A

  • Beverage composition

    JP2016026480A

  • Beverage composition, agent for suppressing occurrence of precipitation, method for suppressing occurrence of precipitation, agent for reducing bitterness, and method for reducing bitter taste

    JP2017093397A

  • Beverage and method for producing the same

    JP2019187365A